IRONMAN – International Registry for Men with Advanced Prostate Cancer
Lay Title:A Registry for Men with Advanced Prostate Cancer
Technical Title: IRONMAN – International Registry for Men with Advanced Prostate Cancer
Disease Type:(1) Metastatic hormone-sensitive prostate cancer, (2) non-metastatic castration-resistant prostate cancer, or (3) metastatic castration-resistant prostate cancer
Basic information: The purpose of this research is to create a registry of data about advanced prostate cancer. This data will be used to learn more about advanced prostate cancer treatments (such as their outcomes and how they are used differently internationally) and the experience and quality of life of patients with advanced prostate cancer. The study also aims to identify clinical and molecular disease subtypes to help researchers understand how different people respond to different cancer treatments.
Research Procedures (not a complete list): If you agree to participate in this study, the research team will collect data from your medical records. You will also be asked to complete questionnaires about your symptoms, quality of life, ability to function, medications, ability to work, and financial concerns due to your diagnosis. The study team will also take blood samples at enrollment, each time you change cancer treatment, and at one year follow-up. This blood will be used for biomarker testing, which can help researchers understand how the body responds to different cancer treatments.
Eligibility Criteria (not a complete list):
Inclusion Criteria:
Exclusion Criteria:
For More Detailed Information, Contact:
Read more about this study (NCT03151629) on ClinicalTrials.gov.
